Thai PBS Thai PBS
Sinovac's CoronaVac reduces mortality by 97 percent: Uruguay study

Sinovac's CoronaVac reduces mortality by 97 percent: Uruguay study

15 Sept 00:12 Key points summarised by AI
  • Early results from Uruguay's immunization campaign indicate Sinovac's CoronaVac significantly reduces COVID-19 mortality by 97%, infection by 57%, and intensive care admissions by 95% in individuals who received two doses.
  • These findings contribute crucial data on CoronaVac's efficacy, which has previously shown varied results in scientific publications from other countries like Chile, Brazil, and Turkey.
  • Uruguay, which heavily relies on CoronaVac for over 80% of its vaccinations, also uses the Pfizer-BioNTech jab for high-risk groups, with both vaccines demonstrating strong protective effects.
  • The health ministry emphasizes that these results are preliminary and should be interpreted with caution, as some data is still being processed and direct comparisons between vaccines are not advised due to differing recipient populations.
Read full article
World 1/2
Skip > Skip >